Karol E. Watson, MD is the Chair of the Council on Aspirin for Health and Prevention, is a Professor of Medicine/Cardiology and a board-certified, full-time cardiologist at the Geffen School of Medicine at UCLA, and she holds the John C. Mazziotta Term Chair in Medicine.
In 2017 Dr. Watson was named Cardiologist of the Year, by the California chapter of the American College of Cardiology (ACC). Dr. Watson received her undergraduate degree from Stanford University, her Medical Degree from Harvard Medical School, magna cum laude, and her PhD in Physiology from UCLA.
Currently, Dr. Watson is director of the UCLA Barbra Streisand Women's Heart Health Program at UCLA, Co-Director of the UCLA Program in Preventative Cardiology, and director of the UCLA Fellowship Program in Cardiovascular Diseases. She is also a Principal Investigator for several large NIH studies, and serves on several NIH Steering committees.
She is currently chair of the Clinical Chemistry and Clinical Toxicology Devices Panel of the Food and Drug Administration. Dr. Watson is past Vice President for the Association of Black Cardiologists (ABC); and immediate past chairperson of the scientific advisory board for Womenheart, -the largest national organization for women living with heart disease.
Dr. Watson's more than 100 publications and presentations have addressed many subjects including prevention of heart disease, vascular calcification, hormone replacement therapy, the metabolic syndrome, hypertension, hypercholesterolemia, and. cardiovascular disease in African Americans.